Bruker Corporation (BRKR)

81,36 +0,77 (+0,96 %) À partir de 10:21AM EDT. Marché ouvert.

Bruker Corporation

40 Manning Road
Billerica, MA 01821
United States
978 663 3660
https://www.bruker.com

Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 9 707

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Justin Joseph Ward	Senior Director of Investor Relations & Corporate Development	S.O.	S.O.	S.O.
Mr. J. Brent Alldredge J.D.	General Counsel & Secretary	S.O.	S.O.	1975
Stacey Desrochers	Treasurer & Director of Investor Relations	S.O.	S.O.	S.O.
Dr. Burkhard Prause Ph.D.	President and CEO of Bruker Energy & Supercon Technologies, Inc.	595,96k	S.O.	1967

Les montants ont été établis en date du 31 décembre 2012 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Bruker Corporation en date du 1 avril 2024 est 5. Les scores principaux sont Audit : 7; Société : 7; Droits des actionnaires : 4; Compensation : 3.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.